442 related articles for article (PubMed ID: 30358115)
1. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
[TBL] [Abstract][Full Text] [Related]
2. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
[TBL] [Abstract][Full Text] [Related]
3. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury.
Kuriyama N; Duarte S; Hamada T; Busuttil RW; Coito AJ
Hepatology; 2011 Dec; 54(6):2125-36. PubMed ID: 21898491
[TBL] [Abstract][Full Text] [Related]
5. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.
Anderson CD; Upadhya G; Conzen KD; Jia J; Brunt EM; Tiriveedhi V; Xie Y; Ramachandran S; Mohanakumar T; Davidson NO; Chapman WC
Liver Transpl; 2011 Feb; 17(2):189-200. PubMed ID: 21280192
[TBL] [Abstract][Full Text] [Related]
7. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.
Gupta NA; Kolachala VL; Jiang R; Abramowsky C; Shenoi A; Kosters A; Pavuluri H; Anania F; Kirk AD
Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1088-99. PubMed ID: 25258410
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.
Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402
[TBL] [Abstract][Full Text] [Related]
10. Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response.
Li CX; Lo CM; Lian Q; Ng KT; Liu XB; Ma YY; Qi X; Yeung OW; Tergaonkar V; Yang XX; Liu H; Liu J; Shao Y; Man K
Oncotarget; 2016 May; 7(19):27711-23. PubMed ID: 27050284
[TBL] [Abstract][Full Text] [Related]
11. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice.
Yang HJ; Tang LM; Zhou XJ; Qian J; Zhu J; Lu L; Wang XH
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):619-25. PubMed ID: 26663010
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.
Neri AA; Dontas IA; Iliopoulos DC; Karatzas T
In Vivo; 2020; 34(3):953-964. PubMed ID: 32354880
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody.
Xiao Z; Banan B; Xu M; Jia J; Manning PT; Hiebsch RR; Gunasekaran M; Upadhya GA; Frazier WA; Mohanakumar T; Lin Y; Chapman WC
Transplantation; 2016 Jul; 100(7):1480-9. PubMed ID: 27331362
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.
Ellett JD; Evans ZP; Atkinson C; Schmidt MG; Schnellmann RG; Chavin KD
Liver Transpl; 2009 Sep; 15(9):1101-9. PubMed ID: 19718644
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific overactivation of nuclear erythroid 2 p45-related factor 2-mediated gene expression in myeloid cells decreases hepatic ischemia/reperfusion injury.
Lee LY; Harberg C; Matkowskyj KA; Cook S; Roenneburg D; Werner S; Johnson DA; Johnson JA; Foley DP
Liver Transpl; 2016 Aug; 22(8):1115-28. PubMed ID: 27113842
[TBL] [Abstract][Full Text] [Related]
16. Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury.
Zhang M; Nakamura K; Kageyama S; Lawal AO; Gong KW; Bhetraratana M; Fujii T; Sulaiman D; Hirao H; Bolisetty S; Kupiec-Weglinski JW; Araujo JA
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282830
[TBL] [Abstract][Full Text] [Related]
17. The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
Shaker ME; Trawick BN; Mehal WZ
Biochem Pharmacol; 2016 Jul; 112():90-101. PubMed ID: 27157410
[TBL] [Abstract][Full Text] [Related]
18. Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice.
Li S; Takahara T; Fujino M; Fukuhara Y; Sugiyama T; Li XK; Takahara S
PLoS One; 2017; 12(11):e0187810. PubMed ID: 29121675
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery.
Boteon YL; Attard J; Boteon APCS; Wallace L; Reynolds G; Hubscher S; Mirza DF; Mergental H; Bhogal RH; Afford SC
Liver Transpl; 2019 Jul; 25(7):1007-1022. PubMed ID: 30821045
[TBL] [Abstract][Full Text] [Related]
20. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver.
Sikalias N; Karatzas T; Alexiou K; Mountzalia L; Demonakou M; Kostakis ID; Zacharioudaki A; Papalois A; Kouraklis G
J Invest Surg; 2018 Oct; 31(5):366-377. PubMed ID: 28644700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
